Publications
- Nivolumab plus chemotherapy or ipilimumab in the first-line palliative therapy of esophageal, gastroesophageal junction, and gastric cancer2023 | Faculty of Medicine in Hradec Králové
- Adverse effects of combination immunotherapy in renal cancer, lung cancer, and melanoma +12022 | Faculty of Medicine in Hradec Králové
- How to manage side effects of immunotherapy How to manage side effects of immunotherapy2020 | Faculty of Medicine in Hradec Králové
- Real-accesible novelties in immunotherapy from the perspective of a medical oncologist working in the Czech Republic2020 | Faculty of Medicine in Hradec Králové
- Current possibilities of immunotherapy in the treatment of malignant melanoma2018 | Faculty of Medicine in Hradec Králové
- Radical cystectomy, treatment possibilities, quality of life2017 | Faculty of Medicine in Hradec Králové
- Elderly patients with colon cancer: a medical oncologist's perspective2016 | Faculty of Medicine in Hradec Králové
- The Role of BRAF/MEK Inhibition in Metastatic Malignant Melanoma - a Case Study2016 | Faculty of Medicine in Hradec Králové
- Possible Pitfalls of Ipilimumab Therapy in Malignant Melanoma - a Case Report2015 | Faculty of Medicine in Hradec Králové
- MUC13-miRNA-4647 axis in colorectal cancer: Prospects to identifications of risk factors and clinical outcomes2023 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine
Loading network view...